ALB and arthritic joint disease: Severe arthritis was allowed to develop to a clinical score of ~10 (day 1), then 200 mg/kg rFc-μTP-L309C or HSA as a control was administered for six treatments given on days 1, 3, 5, 7, 9, and 11.